Chemed Corp (CHE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chemed Corp (CHE) has a cash flow conversion efficiency ratio of 0.077x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($83.39 Million) by net assets ($1.08 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Chemed Corp - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Chemed Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CHE liabilities breakdown for a breakdown of total debt and financial obligations.
Chemed Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chemed Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Immunitybio Inc
NASDAQ:IBRX
|
1.356x |
|
Hangzhou Tigermed Consulting
SHE:300347
|
0.020x |
|
Sulzer AG
SW:SUN
|
0.070x |
|
Grupo Financiero Galicia S.A.
BA:GGAL
|
-0.151x |
|
Bank Millennium S.A.
WAR:MIL
|
0.199x |
|
Definity Financial Corp
TO:DFY
|
0.053x |
|
Chongyi Zhangyuan Tungsten Co Ltd
SHE:002378
|
0.116x |
|
SIAM CEMENT UNSP.ADS/1
F:TCM
|
N/A |
Annual Cash Flow Conversion Efficiency for Chemed Corp (1989–2024)
The table below shows the annual cash flow conversion efficiency of Chemed Corp from 1989 to 2024. For the full company profile with market capitalisation and key ratios, see CHE market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.12 Billion | $417.50 Million | 0.373x | +25.14% |
| 2023-12-31 | $1.11 Billion | $330.30 Million | 0.298x | -23.16% |
| 2022-12-31 | $798.72 Million | $309.89 Million | 0.388x | -21.64% |
| 2021-12-31 | $623.27 Million | $308.60 Million | 0.495x | -8.81% |
| 2020-12-31 | $901.20 Million | $489.29 Million | 0.543x | +30.95% |
| 2019-12-31 | $726.61 Million | $301.25 Million | 0.415x | -14.62% |
| 2018-12-31 | $591.33 Million | $287.14 Million | 0.486x | +61.47% |
| 2017-12-31 | $540.35 Million | $162.50 Million | 0.301x | +16.41% |
| 2016-12-31 | $524.10 Million | $135.39 Million | 0.258x | -22.69% |
| 2015-12-31 | $513.25 Million | $171.50 Million | 0.334x | +36.76% |
| 2014-12-31 | $451.36 Million | $110.28 Million | 0.244x | -27.29% |
| 2013-12-31 | $448.89 Million | $150.85 Million | 0.336x | +15.60% |
| 2012-12-31 | $453.29 Million | $131.77 Million | 0.291x | -31.02% |
| 2011-12-31 | $413.68 Million | $174.34 Million | 0.421x | +126.39% |
| 2010-12-31 | $462.05 Million | $86.01 Million | 0.186x | -44.77% |
| 2009-12-31 | $477.16 Million | $160.83 Million | 0.337x | +11.75% |
| 2008-12-31 | $371.59 Million | $112.08 Million | 0.302x | +10.36% |
| 2007-12-31 | $364.35 Million | $99.58 Million | 0.273x | +16.81% |
| 2006-12-31 | $421.36 Million | $98.59 Million | 0.234x | +12.34% |
| 2005-12-31 | $384.18 Million | $80.01 Million | 0.208x | -26.54% |
| 2004-12-31 | $332.09 Million | $94.16 Million | 0.284x | +141.84% |
| 2003-12-31 | $192.69 Million | $22.59 Million | 0.117x | -19.28% |
| 2002-12-31 | $203.28 Million | $29.52 Million | 0.145x | -5.95% |
| 2001-12-31 | $222.52 Million | $34.36 Million | 0.154x | -31.96% |
| 2000-12-31 | $228.41 Million | $51.84 Million | 0.227x | +74.96% |
| 1999-12-31 | $212.00 Million | $27.50 Million | 0.130x | +39.32% |
| 1998-12-31 | $223.40 Million | $20.80 Million | 0.093x | -36.41% |
| 1997-12-31 | $228.10 Million | $33.40 Million | 0.146x | -6.46% |
| 1996-12-31 | $228.70 Million | $35.80 Million | 0.157x | +107.91% |
| 1995-12-31 | $249.70 Million | $18.80 Million | 0.075x | -27.48% |
| 1994-12-31 | $222.50 Million | $23.10 Million | 0.104x | -0.75% |
| 1993-12-31 | $169.20 Million | $17.70 Million | 0.105x | -6.26% |
| 1992-12-31 | $162.20 Million | $18.10 Million | 0.112x | -8.63% |
| 1991-12-31 | $165.40 Million | $20.20 Million | 0.122x | -58.38% |
| 1990-12-31 | $136.30 Million | $40.00 Million | 0.293x | -10.92% |
| 1989-12-31 | $145.10 Million | $47.80 Million | 0.329x | -- |
About Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commer… Read more